Study Of the Relationship Between Covid-19 and cardiovascular disease
DOI:
https://doi.org/10.54097/hset.v45i.7482Keywords:
Cardiovascular disease; Covid-19; cytokine storm; BMI; dyslipidemia.Abstract
Among the deaths caused by Covid, cardiovascular diseases are the most concern. Many people, which look healthy, lost their lives because of some cardiovascular diseases, even after they thought they have already recovered from Covid. This article mainly focusses on the relationship between the Covid and cardiovascular diseases and promote the point that Covid-19 can improve the possibility of cardiovascular disease in several ways. First, Covid may direct make damage to heart and ruin the cardiovascular system. Second, Covid can damage other systems such as lung, and then damage the heart indirectly. Also, Covid lockdown can influence people’s activities and change people’s lifestyle. This may also contribute to the possibility of cardiovascular disease. This founding suggests that government and some health organization should prepare for the Covid-19 pandemic's potential considerable contribution to an increase in the burden of cardiovascular illnesses.
Downloads
References
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. Sep 2020
Grasselli G, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020
Goyal P, Choi JJ, Pinheiro LC, et al Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020 Jun
Kevin J. Clerkin, Justin A. Fried, Jayant Raikhelkar, et al. COVID-19 and cardiovascular disease. Circulation. Mar 2020.
Khan, M.S., Shahid, I., Anker, S.D. et al. Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med. Dec 2020.
Chilazi M, Duffy EY, Thakkar A, Michos ED. COVID and Cardiovascular Disease: What We Know in 2021. Curr Atheroscler Rep. May 2021
Madjid M, Aboshady I, Awan I, Litovsky S, Casscells SW. Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J. 2004
Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS, Kahan J, Lansdale KN, LeMoss NM, Murthy SB, Stieg PE, Fink ME, Iadecola C, Segal AZ, Cusick M, Campion TR Jr, Diaz I, Zhang C, Navi BB. Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. JAMA Neurol. Jul 2020
Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA. 2020
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.Lancet. Mar 2020
Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, Wang LF, Gao H, Wang Y, Dong CF, et al. First case of COVID-19 infection with fulminant myocarditis complication: case report and insights preprints. 2020
Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM, Butany J. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009
Zheng, YY., Ma, YT., Zhang, JY. et al. COVID-19 and the cardiovascular system. Nat Rev. 2020
Xu E, Xie Y, Al-Aly Z. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2023 Jan
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
